In a significant development that promises to disrupt the treatment landscape for severe respiratory conditions, Upstream Bio, Inc. is set to unveil groundbreaking data on the potential of Verekitug, at the distinguished EAACI Congress 2025. The clinical-stage company, which is making strides in the development of innovative treatments for inflammatory diseases, will spotlight the efficacy, […]